Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    EILATEDU 2019 - 8th Eilat International Educational Course: PHARMACOLOGICAL TREATMENT OF EPILEPSY

    View: 1239

    Website https://www.eilatedu2019.com | Want to Edit it Edit Freely

    Category epilepsy; treatment; pharmacology; neurology

    Deadline: November 28, 2018 | Date: September 08, 2019-September 13, 2019

    Venue/Country: Jerusalem, Israel

    Updated: 2017-12-19 00:19:34 (GMT+9)

    Call For Papers - CFP

    GUIDELINES FOR BURSARY APPLICATION

    Bursaries will be made available to young scientists (45 years and younger). The bursary will include waiver of course registration fee as well as accommodation in a shared room and meals during the course.

    Potential candidates are kindly requested to submit the following via the online submission link (https://www.eilatedu2019.com/bursaries)

    above no later than November 28, 2018.

    -CV

    -Recommendation letter from head of their department or head of research lab

    -Abstract based on research work

    Kindly note that submission of an abstract is mandatory and applications will not be considered without an abstract.

    These documents will be evaluated by the Course Organizing Committee and applicants will be notified of the decision no later than March 2019.

    The number of bursaries is restricted and it is therefore recommended that candidates submit their applications as soon as possible.

    Deadline for Bursary Submission: November 28, 2018


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.